Thomas B. Cueni is Director General of IFPMA since 1 February 2017. He is Chair of the Business at OECD Health Committee and a member of the Board of Directors of the City Cancer Challenge, an initiative aiming to improve cancer care in major cities in low- and middle-income countries. Thomas Cueni also serves as Chair of the Board of the cross-sectoral AMR Industry Alliance, a group, which includes more than 100 companies and associations representing Rx pharma, generics, biotech, and diagnostics.
Prior to joining IFPMA he was Secretary General of Interpharma, the association of pharmaceutical research companies in Switzerland and served on the Council of IFPMA and Board and committees of EFPIA.
Prior to his appointment with Interpharma, Thomas Cueni had a career as a journalist, inter alia as London correspondent for the “Basler Zeitung” and “Der Bund”, and he served as a Swiss career diplomat with postings in Paris (OECD) and Vienna (IAEA, UNIDO). He studied at the University of Basle, the London School of Economics, and the Geneva Graduate Institute for International Studies, and has Master degrees in economics (University of Basel) and politics (London School of Economics, LSE).